HEALTHTECH SECURITY

Henry Ford Health and the PINC AI™ Applied Sciences Team Lead Action to Advance Health Equity

Henry Ford Health | November 21, 2022 | Read time : 03:00 min

Henry Ford

Henry Ford Innovations one of the nation's leading healthcare innovation programs, recently hosted the inaugural "Advancing Health Equity Through Innovation and Collaboration" event in partnership with the PINC AI™ Applied Sciences team, a leading provider of advanced analytics, technology solutions and clinical research support services to the life sciences industry.  

The initiative's purpose was to turn health equity conversations into action by taking measurable steps towards improving the health of millions. Participants included global leaders in life sciences, as well as Henry Ford Health innovators who are already implementing programs to address health disparities in groups who have been historically marginalized and underrepresented.

"Part of innovating is looking for partners to expand successful test programs and develop new ones. Partnerships like the ones we're forging with these corporate partners will create a true impact in addressing health equity. We are thrilled to have the opportunity to share our findings with national leaders in the life sciences and pharmaceutical industries and chart a path forward to bring these solutions to help more people."

Lisa Prasad, Henry Ford Health's Chief Innovation Officer and leader of Henry Ford Innovations

 

The two-day event in late October included a presentation of case studies from successful Henry Ford Health programs, including community-based partnerships to increase health screenings. That program found that a lack of trust in institutions can deter people from getting preventative care and that using community partners for healthcare services can reduce barriers and increase access to care. Other case studies covered programs to improve hypertension in young African American men and reduce infant mortality among underserved populations. The unique action-focused event allowed leaders from Henry Ford Health, the PINC AI™ Applied Sciences team and collaborators from eight global life sciences companies to meet, connect and work together on ways to amplify and expand pilot programs.

"The impactful work Henry Ford Health already has under way makes Detroit an ideal location to look for solutions to reduce health inequities across the country," said Denise Juliano, Life Sciences Group Vice President, PINC AI™ Applied Sciences. "PINC AI™ Applied Sciences partners with leaders in healthcare to improve health outcomes and advance equitable care for all people. This initiative was a great step forward to accelerate our efforts to address the challenges of health inequities that continue to persist."

Because of Henry Ford Health's community connections and its long-standing work to improve diversity, equity, inclusion and justice (DEIJ), the health system is a leader in researching and tackling health disparities in Detroit. In 2021, Henry Ford launched a new initiative to improve the representation of African American people in cancer clinical trials. It was an important collaboration, especially considering that recent research shows 85 percent of participants in clinical trials are white. Another program supported by HFI provides medical mentorship and internship opportunities for Detroit-based high school students. Both initiatives serve as examples of the meaningful change health and life sciences organizations can affect together.

"This initiative is an example of how Henry Ford's commitment to DEIJ extends beyond ideas and connects directly to action," said Ikenna Okereke, M.D., Henry Ford Health's Vice Chair of Surgery and Director of Thoracic Surgery. "Through Henry Ford's Department of Surgery High School Mentorship Program, I've seen firsthand how programs that work in other communities can grow for a larger impact. I'm excited to be a part of the next chapter in creating more programs and initiatives to address health disparities."

Henry Ford Health and the PINC AI™ Applied Sciences team will now work with the summit's participating partners to strengthen and scale solutions to advance health equity.

About Henry Ford Health
Serving communities across Michigan and beyond, Henry Ford Health is committed to partnering with patients and members along their entire health journey. Henry Ford Health provides a full continuum of services – from primary and preventative care, to complex and specialty care, health insurance, a full suite of home health offerings, virtual care, pharmacy, eye care and other healthcare retail.

It is one of the nation's leading academic medical centers, recognized for clinical excellence in cancer care, cardiology and cardiovascular surgery, neurology and neurosurgery, orthopedics and sports medicine, and multi-organ transplants. Consistently ranked among the top five National Institutes of Health (NIH)-funded institutions in Michigan, Henry Ford Health engages in more than 2,000 research projects annually. Equally committed to educating the next generation of health professionals, Henry Ford Health trains more than 4,000 medical students, residents, and fellows every year across 50+ accredited programs. 

With more than 33,000 valued team members, Henry Ford Health is also among Michigan's largest and most diverse employers, including nearly 6,000 physicians and researchers from the Henry Ford Medical Group, Henry Ford Physician Network and Jackson Health Network.

The health system is led by President and CEO Robert G. Riney and serves a growing number of customers across 250+ locations throughout Michigan including five acute care hospitals, two destination facilities for complex cancer and orthopedics and sports medicine care, three behavioral health facilities, primary care and urgent care centers.

About the PINC AI™ Platform
PINC AI™ is the technology and services platform of Premier Inc. With more than 20 years' worth of cost, quality and operational data gleaned from 45 percent of U.S. hospital discharges, 812 million hospital outpatient and clinic encounters and 131 million physician office visits, the PINC AI™ platform provides actionable intelligence to help improve outcomes, support improved financial performance and enable success in new, alternative payment models. PINC AI™ offerings rely on advanced analytics to identify improvement opportunities, consulting services for clinical and operational design, and workflow solutions to hardwire sustainable change. The PINC AI™ platform is also the data engine powering Premier's newest brands – Remitra™ and Contigo Health®. 

Spotlight

Envision Healthcare is one of the nation's leading medical groups, delivering care when and where it's needed most. Operating in more than 650 facilities, Envision provides care mainly in the areas of emergency medicine, hospital medicine, anesthesiology, radiology, trauma surgery and neonatology.

Spotlight

Envision Healthcare is one of the nation's leading medical groups, delivering care when and where it's needed most. Operating in more than 650 facilities, Envision provides care mainly in the areas of emergency medicine, hospital medicine, anesthesiology, radiology, trauma surgery and neonatology.

Related News

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

Masimo and Philips Introduce Masimo W1 Watch As Part of a Global Partnership

Masimo | January 19, 2023

On January 18, 2023, Masimo and Royal Philips announced an extension of their partnership to expand the capabilities for patient monitoring in home telehealth applications. Masimo W1™ advanced health tracking watch will unite with Philips' enterprise patient monitoring ecosystem, advancing telemonitoring and telehealth. Masimo W1 is the first wristwatch to provide continuous, precise pulse oximetry measures and other health-related information. Masimo's secure health data cloud will transmit patient information to Philips' patient monitoring environment thereby, facilitating remote clinician monitoring. Hospital experts will remotely monitor patients' vital signs while they go about their regular lives. Physicians can confidently discharge patients, knowing that Masimo W1 will monitor their vital signs while Philips dashboards will scrutinize their physiological status. It will enable physicians and nurses to detect a patient's deterioration earlier and provide better care. This innovative combination of monitoring and networking technology will offer numerous opportunities, including early discharge initiatives, hospital-at-home programs, and the management of chronic illness. Bilal Muhsin, Chief Operating Officer of Masimo Healthcare, expressed, "Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere, and is an important part of our multi-year plan to bring the best of hospital monitoring to the home while continuing to improve access to quality hospital care." (Source – Business Wire) About Masimo Masimo develops and manufactures innovative, non-invasive patient monitoring technologies, including medical devices and sensors. The company is making a measurable difference in the world by saving, extending, and improving the lives of people of all ages. For over 30 years, its innovative medical technologies and non-invasive patient monitoring solutions have solved 'unsolvable' problems. The result is a portfolio of clinically-proven products that lead the way in innovation, performance, and patient safety by giving healthcare providers the information they need to optimize clinical decision-making. Through the Masimo Hospital AutomationTM platform, Masimo connectivity, automation, and telehealth and telemonitoring solutions are improving and automating care delivery both in and out of the hospital.

Read More

HEALTHTECH SECURITY, MEDICAL DEVICES

Triad HealthCare Network Harnesses Medication Data to Improve Outcomes for High-Risk Patients

DrFirst | December 14, 2022

Triad HealthCare Network, a provider-led accountable care organization and health technology pioneer DrFirst announced an initiative to improve medication adherence among high-risk patient populations across five counties in North Carolina. Fast access to prescription fill data will empower providers to identify patients with chronic conditions who may not be taking their medications as prescribed and intervene early to alleviate barriers to adherence that can lead to gaps in care, poor outcomes, and hospital readmissions. Every year, medication non-adherence due to factors such as cost, access, coverage status, dosage complexity, or concerns about side effects causes about 125,000 deaths. In addition to needless human suffering, it costs nearly $250 billion to the U.S. healthcare system. Giving providers access to up-to-date prescription fill data can lead to better adherence and shed light on other health-related issues, which creates an opportunity for providers to enhance patient care. "Since patients' medication records are typically fragmented across the care continuum, our clinicians are excited about DrFirst's ability to provide current, comprehensive, and easy-to-access medication history, which will enhance our ability to deliver the right care at the right time. This ability is especially important among patients at high risk of complications, such as those with diabetes or congestive heart failure. In addition, we will be able to further improve care coordination and prevent avoidable admissions and emergency visits due to medication issues." Hanna Park, PharmD, Executive Director of Value-based Performance at Triad HealthCare Network MedHx PRM is based on DrFirst's award-winning MedHx, which streamlines medication reconciliation workflows by providing the most accurate and clinically actionable medication history for individual patients at hospital admission and in the emergency department. For population risk management, MedHx PRM expands prescription fill data to a population of patients to enable risk stratification and easy identification of those who would benefit from early and targeted care interventions. Using clinical analytics, care managers can create panels of high-risk patients or import them from an electronic health record (EHR) system and then easily identify those who are not adhering to medication therapies. In particular, ACOs need access to timely and accurate data to ensure patients get appropriate care while avoiding unnecessary duplication of services and preventing medical errors. "For ACOs to deliver on their promise of coordinated patient care, they need to gather clinical data from multiple systems and structure it in a way that makes it useful for clinicians," said G. Cameron Deemer, president of DrFirst. "Triad HealthCare Network is the first ACO to use MedHx PRM to collect medication data from payers, prescription benefit managers, and EHRs. By pulling thousands of de-duplicated patient medication histories automatically and quickly—usually within hours rather than months—clinicians can meaningfully intervene with patients before they end up back in their local hospital's emergency department."  About Triad HealthCare Network Triad HealthCare Network is a provider-led accountable care organization located in Greensboro, North Carolina. It serves nearly 200,000 people in Alamance, Guilford, Randolph, Rockingham, and part of Forsyth counties. THN is sponsored by Cone Health and is governed and operated by a board of managers and a physician-led operating committee. We believe by working together, our network can provide the right care, at the right place, at the right time. About DrFirst Since 2000, DrFirst has pioneered healthcare technology solutions and consulting services that securely connect people at touchpoints of care to improve patient outcomes. We create unconventional solutions that solve care collaboration, medication management, price transparency, and adherence challenges faced in healthcare. We unite the Healthiverse—the interconnected healthcare universe—by providing our clients with real-time access to the information they need, exactly when and how they need it, so patients get the best care possible. DrFirst solutions are used by nearly 325,000 healthcare professionals, including 220,000 prescribers, 70,000 pharmacies, 300 EHRs and health information systems, and 1,500 hospitals in the U.S. and Canada.

Read More

FUTURE OF HEALTHCARE,DIGITAL HEALTHCARE

MindMaze and Vibra Healthcare Partner to Deliver Advanced Digital Medicine and Neurorehabilitation Solutions for Patients from Clinic-to-Home

Vibra Healthcare | December 08, 2022

MindMaze, a global pioneer in the development of AI-driven neurotechnology, and Vibra Healthcare, a leader in post-acute hospital patient care, are excited to announce a partnership to deploy MindMaze’s digital health technology platform in-clinic and at-home for patients within select Vibra hospitals in Kentucky and California as a first step. MindMaze’s digital neurotherapeutic solutions are designed to help patients regain function through digitally-enabled assessments as well as behavioral training of holistic motor, cognitive and cardiovascular systems following Stroke/TBI, SCI, Parkinsons Disease and other neurological indications. This innovative partnership will enable clinicians to provide patients in the clinic and at home with interventions at dosage and intensity levels that are orders of magnitude higher than the current standard of care. MindMaze delivers novel software-based interventions and assessments for neurological diseases, as well as capabilities that monitor and measure patient function during the long-term management of chronic disease. The partnership will facilitate a large-scale roll-out of MindMaze solutions to improve care across in-patient, post-acute, community sub-acute and home-based care environments. The goal is to deliver a substantial increase in training and treatment for Vibra’s patients, as well as to offer seamless and coordinated transitions in care as patients are treated within the Vibra Healthcare System which operates and manages over 90 specialty hospitals as well as transitional care units/facilities in 19 states. The need for solutions that deliver superior outcomes—as well as those that support patients during the lifetime of their chronic condition—has never been greater. Nearly 100 million Americans are afflicted by a neurological disease, as reported in the Annals of Neurology, resulting more often than not in costly disability that can worsen over time. Nearly 50% of the total health burden in the United States is due to morbidity and disability. Consolidated studies have demonstrated that high dose, high intensity training can improve outcomes in traditionally hard-to-treat neurological indications. MindMaze believes that multimodal technology is fundamental to address the growing challenges faced by clinicians, patients and caregivers alike. “MindMaze is committed to redefining neuro recovery across the continuum of care through the development evidence-driven solutions for patients with serious neurological conditions. We are focused on providing clinicians with powerful, digitally-enabled, cutting-edge tools, while also empowering patients and their families with easy-to-use, engaging and accessible solutions. In Vibra we have found a world-class partner with both the commitment and true capability to deliver a step-change in brain health as well as meaningful improvements in patient outcomes.” Tej Tadi, Founder, Chairman & CEO of MindMaze “Vibra is committed to delivering the best possible care for our patients and the best value for our customers,” said Brad Hollinger, Founder, Chairman and CEO of Vibra Healthcare. “Our facilities have consistently ranked among the top-rated hospitals and rehabilitation facilities in the country, and we are always looking for ways to improve upon our incredibly high standards. We strongly believe that innovative technology in AI is the pioneering path forward to dramatically improve patient outcomes in the most cost-effective way. MindMaze has impressed our team not just with the power of their technological capabilities, but also with their experience in deploying real-world care pathways for patients with Stroke and other neurological conditions in countries around the world.” About MindMaze Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery. With a presence in over 15 countries, its mission is to accelerate the brain’s ability to recover, learn and adapt. The company has two core divisions – Healthcare and Labs – working collaboratively at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence. MindMaze Healthcare is advancing a universal platform for brain health with breakthrough solutions to some of the world’s most challenging problems in neurology, including stroke, Parkinson’s disease and Alzheimer’s disease. MindMaze Labs, the company’s R&D innovation hub, is focused on the future of human computing – working across multiple industries to innovate and build the next generation of human-machine interfaces. The company has offices in Lausanne, Baltimore, London, Paris and Mumbai. About the Vibra Healthcare Vibra Healthcare, LLC is a post-acute care provider based in Mechanicsburg, PA that is focused on the development, acquisition, and operation of freestanding specialty care hospitals, medical rehabilitation hospitals, and outpatient physical rehabilitation centers. Teams of highly trained specialists lead clinical programs at Vibra’s specialty hospitals for rehabilitating patients who suffer from strokes, multiple traumas, major orthopedic, neurologic, cardiac, and respiratory conditions. Vibra and its affiliates currently employ over 10,000 employees and own, operate, and manage over 90 specialty hospitals, transitional care units/facilities, and hospital-based outpatient physical therapy locations in 19 states.

Read More